[HTML][HTML] Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward

V Iyer, C Rangel-Barajas, TJ Woodward… - Pharmacological …, 2022 - Elsevier
Blockade of cannabinoid type 1 (CB 1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward.

V Iyer, C Rangel-Barajas, TJ Woodward… - Pharmacological …, 2022 - europepmc.org
Blockade of cannabinoid type 1 (CB 1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward

V Iyer, C Rangel-Barajas… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
Blockade of cannabinoid type 1 (CB 1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

[PDF][PDF] Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward

V Iyer, C Rangel-Barajas, TJ Woodward… - Pharmacological …, 2022 - researchgate.net
Blockade of cannabinoid type 1 (CB1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

[HTML][HTML] Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward

V Iyer, C Rangel-Barajas, TJ Woodward… - Pharmacological …, 2022 - ncbi.nlm.nih.gov
Blockade of cannabinoid type 1 (CB 1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward.

V Iyer, C Rangel-Barajas, TJ Woodward, A Kulkarni… - 2022 - cabidigitallibrary.org
Blockade of cannabinoid type 1 (CB1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …

Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward.

V Iyer, C Rangel-Barajas, TJ Woodward… - Pharmacological …, 2022 - europepmc.org
Blockade of cannabinoid type 1 (CB 1)-receptor signaling decreases the rewarding
properties of many drugs of abuse and has been proposed as an anti-addiction strategy …